Glenmark initiates process of reorganising itself into three different entities

05 Sep 2019

Glenmark Pharmaceuticals has initiated the process of reorganising itself into three different entities and expects the process to be completed in the current fiscal year.

This reorganisation is designed to place Glenmark on an accelerated trajectory and these three different entities will together make up the Glenmark group of companies.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

503.40 15.70 (3.22%) Dec 04, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 568.85
Dr. Reddys Lab 4907.30
Lupin 932.85
Piramal Enterprises 1468.40
Cadila Healthcare 471.00
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback